173 related articles for article (PubMed ID: 34768110)
1. Proteome biology of primary colorectal carcinoma and corresponding liver metastases.
Fahrner M; Bronsert P; Fichtner-Feigl S; Jud A; Schilling O
Neoplasia; 2021 Dec; 23(12):1240-1251. PubMed ID: 34768110
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
[No Abstract] [Full Text] [Related]
3. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Voß H; Wurlitzer M; Smit DJ; Ewald F; Alawi M; Spohn M; Indenbirken D; Omidi M; David K; Juhl H; Simon R; Sauter G; Fischer L; Izbicki JR; Molloy MP; Nashan B; Schlüter H; Jücker M
Clin Exp Metastasis; 2020 Dec; 37(6):649-656. PubMed ID: 33099724
[TBL] [Abstract][Full Text] [Related]
4. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
[TBL] [Abstract][Full Text] [Related]
5. High-Precision Quantitative Analysis Reveals Carcinoembryonic Protein Expression Differs Among Colorectal Cancer Primary Foci and Metastases to Different Sites.
Zhu Y; Zhang Q; Wei C; Hu Y; Gong H; Liu Y; Lai H; Feng Y; Lin Y
Technol Cancer Res Treat; 2021; 20():15330338211037175. PubMed ID: 34342245
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of β1 integrin expression in colorectal liver metastases.
Vassos N; Rau T; Merkel S; Feiersinger F; Geppert CI; Stürzl M; Hohenberger W; Croner RS
Int J Clin Exp Pathol; 2014; 7(1):288-300. PubMed ID: 24427350
[TBL] [Abstract][Full Text] [Related]
7. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
8. Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1.
Kaihara T; Kawamata H; Imura J; Fujii S; Kitajima K; Omotehara F; Maeda N; Nakamura T; Fujimori T
Cancer Sci; 2003 Feb; 94(2):166-72. PubMed ID: 12708492
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Protein Purification Techniques and Effects of Storage Duration on LC-MS/MS Analysis of Archived FFPE Human CRC Tissues.
Rossouw SC; Bendou H; Blignaut RJ; Bell L; Rigby J; Christoffels A
Pathol Oncol Res; 2021; 27():622855. PubMed ID: 34257588
[TBL] [Abstract][Full Text] [Related]
10. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
11. Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases.
Shen Z; Wang B; Luo J; Jiang K; Zhang H; Mustonen H; Puolakkainen P; Zhu J; Ye Y; Wang S
J Proteomics; 2016 Jun; 142():24-32. PubMed ID: 27178108
[TBL] [Abstract][Full Text] [Related]
12. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas.
Zhang YJ; Chen JW; He XS; Zhang HZ; Ling YH; Wen JH; Deng WH; Li P; Yun JP; Xie D; Cai MY
EBioMedicine; 2018 Feb; 28():62-69. PubMed ID: 29396302
[TBL] [Abstract][Full Text] [Related]
13. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
[TBL] [Abstract][Full Text] [Related]
14. Proteome analysis of formalin-fixed paraffin-embedded colorectal adenomas reveals the heterogeneous nature of traditional serrated adenomas compared to other colorectal adenomas.
Sohier P; Sanson R; Leduc M; Audebourg A; Broussard C; Salnot V; Just PA; Pasmant E; Mayeux P; Guillonneau F; Romagnolo B; Perret C; Terris B
J Pathol; 2020 Mar; 250(3):251-261. PubMed ID: 31729028
[TBL] [Abstract][Full Text] [Related]
15. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
Stessels F; Van den Eynden G; Van der Auwera I; Salgado R; Van den Heuvel E; Harris AL; Jackson DG; Colpaert CG; van Marck EA; Dirix LY; Vermeulen PB
Br J Cancer; 2004 Apr; 90(7):1429-36. PubMed ID: 15054467
[TBL] [Abstract][Full Text] [Related]
16. ERCC1 expression in advanced colorectal cancer and matched liver metastases.
Olsen LM; Fiehn AK; Hasselby JP
Pathol Res Pract; 2020 Mar; 216(3):152826. PubMed ID: 32008866
[TBL] [Abstract][Full Text] [Related]
17. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Numata M; Yamamoto N; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Yukawa N; Rino Y; Masuda M; Miyagi Y
Eur J Surg Oncol; 2013 Jun; 39(6):655-61. PubMed ID: 23523318
[TBL] [Abstract][Full Text] [Related]
18. The influence of metastatic site on the expression of CEA and cellular localization of β-catenin in colorectal cancer.
Rao US; Hoerster NS; Thirumala S; Rao PS
J Gastroenterol Hepatol; 2013 Mar; 28(3):505-12. PubMed ID: 23216017
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
[TBL] [Abstract][Full Text] [Related]
20. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
